SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:0007 0920 OR L773:1532 1827 srt2:(1995-1999)"

Sökning: L773:0007 0920 OR L773:1532 1827 > (1995-1999)

  • Resultat 11-20 av 100
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  • Ejeskär, K, et al. (författare)
  • Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene.
  • 1998
  • Ingår i: British journal of cancer. - : Springer Science and Business Media LLC. - 0007-0920 .- 1532-1827. ; 77:11, s. 1787-91
  • Tidskriftsartikel (refereegranskat)abstract
    • Neuroblastoma is a heterogeneous childhood tumour of the sympathetic nervous system, in which deletions of chromosomal region 1p and amplification of the MYCN oncogene correlate with aggressive tumour behaviour. However, the majority of neuroblastoma tumours show neither of these aberrations, indicating that other chromosomal regions may be involved in tumorigenesis. Here, we report findings of loss of heterozygosity (LOH) on chromosome 3. In our neuroblastoma material, nine of 59 (15.3%) tested tumours showed allelic loss of chromosome 3p markers. We found significant clinical and biological differences between tumours with the loss of one entire chromosome 3 vs tumours with partial loss in chromosome region 3p. All children with tumours with whole chromosome 3 loss are long-term survivors, whereas all children with tumours showing partial 3p LOH have died from tumour progression. A consensus region found to be deleted in all the tumours with 3p deletions was defined by markers D3S1286 and D3S1295, i.e. 3p25.3-p14.3, distal to the FHIT gene.
  •  
12.
  •  
13.
  •  
14.
  •  
15.
  • Frisch, Morten, et al. (författare)
  • Benign anal lesions, inflammatory bowel disease and risk for high-riskive and -negative anal carcinoma
  • 1998
  • Ingår i: British Journal of Cancer. - 0007-0920 .- 1532-1827. ; 78:11, s. 1534-1538
  • Tidskriftsartikel (refereegranskat)abstract
    • A central role in anal carcinogenesis of high-risk types of human papillomaviruses (hrHPV) was recently established, but the possible role of benign anal lesions has not been addressed in hrHPV-positive and -negative anal cancers. As part of a population-based case-control study in Denmark and Sweden, we interviewed 417 case patients (93 men and 324 women) diagnosed during the period 1991-94 with invasive or in situ anal cancer, 534 patients with adenocarcinoma of the rectum and 554 population controls. Anal cancer specimens (n = 388) were tested for HPV by the polymerase chain reaction. Excluding the 5 years immediately before diagnosis, men, but not women, with anal cancer reported a history of haemorrhoids [multivariate odds ratio (OR) 1.8; 95% confidence interval (CI) 1.04-3.2] and unspecific anal irritation (OR 4.5; CI 2.3-8.7) significantly more often than controls. Women with anal cancer did not report a history of benign anal lesions other than anal abscess to any greater extent than controls, but they had used anal suppositories more often (OR 1.5; CI 1.1-2.0). Patients with hrHPV in anal cancer tissue (84%) and those without (16%) reported similar histories of most benign anal lesions, but anal fissure or fistula was more common among hrHPV-positive cases. Ulcerative colitis and Crohn's disease, reported by <1% of study participants, were not associated with anal cancer risk. The higher proportion of hrHPV-positive anal cancers among case patients with anal fissure or fistula suggests that such mucosal lesions may provide direct viral access to basal epithelial layers. Since risk associations with benign anal lesions in men may be confounded by unreported sexual behaviour, and since risk associations in women were generally negative, it seems unlikely that benign anal lesions act as promoters in hrHPV-associated anal carcinogenesis. Moreover, benign anal lesions appear not to be linked to an alternative, hrHPV-unassociated causal pathway to anal cancer. Ulcerative colitis and Crohn's disease were not supported as causal factors for anal cancer.
  •  
16.
  •  
17.
  • Gentile, Massimiliano, et al. (författare)
  • Frequent allelic losses at 11q24.1–q25 in young women with breast cancer : association with poor survival
  • 1999
  • Ingår i: British Journal of Cancer. - : Springer Science and Business Media LLC. - 0007-0920 .- 1532-1827. ; 80:5/6, s. 843-849
  • Tidskriftsartikel (refereegranskat)abstract
    • Previous studies have demonstrated that the pathological features of breast cancer are more aggressive in younger women than in their older counterparts, and that young age may be an independent marker for adverse prognosis. These findings have raised the question whether these differences are also present at the molecular level. In order to characterize the genetic alterations associated with early-onset breast cancer, 102 cases selected for age under 37 at diagnosis were examined for loss of heterozygosity (LOH) at nine different loci on chromosomes 11, 13 and 17. Ninety cases (88%), exhibited LOH for at least one marker. The D17S855 marker, intragenic in the BRCA1 gene, showed a high proportion of LOH (63%), whereas the intragenic marker for the TP53 gene, HP53, exhibited LOH in 43% of the cases. On chromosome 11, frequencies of LOH peaked at the D11S969 and D11S387 markers, which expressed LOH in 53% and 48% of the informative cases, whereas D11S1818, which is proximate to the ATM gene, exhibited an LOH frequency of 24%. A statistically significant correlation was found between LOH at the D11S387 marker and poor survival (P = 0.028). No such correlation was found for the adjacent D11S969 marker, located approximately 500 kb centromeric to D11S387. We conclude that one or more as yet unidentified genes, situated in chromosome bands 11q24.1–q25, could be involved in the initiation and/or progression of breast cancer in younger women.
  •  
18.
  •  
19.
  •  
20.
  • Gustafson, Pelle, et al. (författare)
  • Prognostic implications of various models for calculation of S-phase fraction in 259 patients with soft tissue sarcoma
  • 1999
  • Ingår i: British Journal of Cancer. - : Springer Science and Business Media LLC. - 1532-1827 .- 0007-0920. ; 79, s. 1205-1209
  • Tidskriftsartikel (refereegranskat)abstract
    • The S-phase fraction (SPF) in flow cytometric DNA histograms in soft tissue sarcoma (STS) can be calculated in various ways. The traditional planimetric method of Baisch has been shown to be prognostic, but is hampered by a failure rate of around 40%. We therefore tested other models to see if this rate could be decreased with retained prognostic value. In 259 STS of the locomotor system the SPF was calculated according to Baisch and with commercial parametric MultiCycle software using different corrections for background. Using the Baisch model, 159 histograms could be evaluated for SPF. The 5-year metastasis-free survival rate (MFSR) was 0.94 for the low-risk group (defined with SPF), and 0.53 for the high-risk group. In the low-risk group, four of the seven patients who developed metastasis did so after 5 years Using the MultiCycle software, SPF could be calculated in 253 tumours. Depending on type of background correction used, the 5-year MFSR varied between 0.67 and 0.82 for the low-risk group, and between 0.47 and 0.53 for the high-risk group. The late metastasis pattern in the low-risk group was never seen using the MultiCycle software. We conclude that in paraffin archival material, calculation of SPF according to Baisch is preferable in clinical use due to better separation between low-risk and high-risk groups, and also the possibility to identify patients who metastasize late.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 11-20 av 100
Typ av publikation
tidskriftsartikel (97)
konferensbidrag (3)
Typ av innehåll
refereegranskat (97)
övrigt vetenskapligt/konstnärligt (3)
Författare/redaktör
Glimelius, B (10)
Bergstrom, R (9)
Olsson, Håkan (8)
Lindmark, G (7)
Ahlman, Håkan, 1947 (5)
Wängberg, Bo, 1953 (5)
visa fler...
Nilsson, Ola, 1957 (5)
Steineck, G (5)
Adami, Hans Olov (4)
Adami, HO (4)
Adolfsson, J. (4)
Ekbom, A (4)
Hirano, T (4)
Fernö, Mårten (3)
Tretli, S (3)
Lindblom, A (3)
Ringborg, U (3)
Bergström, Reinhold (3)
Baldetorp, Bo (3)
Tribukait, B (3)
Tisell, Lars-Eric, 1 ... (3)
Forssell-Aronsson, E ... (3)
Nakamura, K. (2)
Gustafsson, L (2)
Fredrikson, Mats (2)
Glimelius, Bengt (2)
Pukkala, E (2)
Persson, I. (2)
Gustafsson, M. (2)
Hatschek, T (2)
Björk-Eriksson, Thom ... (2)
Kogner, P (2)
Hansson, J. (2)
Svanberg, Sune (2)
Fredrikson, M (2)
Trichopoulos, D (2)
Bergström, R (2)
Boyle, P. (2)
Persson, Ingemar (2)
Karlsson, E (2)
Dickman, P (2)
Lewensohn, R. (2)
Svanberg, Katarina (2)
Michaelis, J (2)
Petridou, E (2)
Larsson, A (2)
Fjälling, M (2)
Kölby, Lars, 1963 (2)
Borg, Åke (2)
Sparen, P (2)
visa färre...
Lärosäte
Karolinska Institutet (61)
Uppsala universitet (20)
Lunds universitet (17)
Göteborgs universitet (10)
Linköpings universitet (6)
Södertörns högskola (1)
visa fler...
Chalmers tekniska högskola (1)
visa färre...
Språk
Engelska (99)
Odefinierat språk (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (29)
Naturvetenskap (5)
Samhällsvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy